Capstan Therapeutics Begins Phase 1 Trial of CAR-T Therapy for Autoimmune Disease
Capstan Therapeutics, a biotechnology company spun out of Penn, has initiated its Phase 1 trial of an in vivo CAR-T therapy.
REGENXBIO’s Gene Therapy Updates for Hunter Syndrome and DMD
REGENXBIO was co-founded by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.
Penn Startup Vivodyne Raises $40 Million to Advance Human Tissue Testing Platform
Vivodyne was co-founded by Dan Huh, PhD, Professor of Bioengineering in Penn Engineering and CEO Andrei Georgescu.,
Research at Penn Report Highlights the Global Impact of Penn’s Research
Penn has over 5,000 research faculty spanning 200+ centers.
Philadelphia Ranks #13 Globally, Climbing Up 12 Spots, in 2025 Global Startup Ecosystem Report
The 2025 Global Startup Ecosystem Report has been released.
Smart Dental Implant Developed by Penn Researchers
Researchers developed a smart dental implant that prevents gum inflammation and plaque formation.
World’s First Patient Treated with Personalized CRISPR Gene Editing Therapy through Penn Medicine and CHOP Collaboration
In a history-making breakthrough, a baby diagnosed with a rare genetic disorder was successfully treated with a customized CRISPR gene editing therapy.
Penn Engineering Hosts “AI at the Crossroads: Ethics, Innovation & Impact” During Philly Tech Week
Melissa Kelly, PhD, Deputy Managing Director of PCI, served as a panelist and shared her insights on the impact of AI.
PCI Celebrates Philly Tech Week by Hosting “Innovate & Inspire: Research Panel & Pitch Competition”
The 15th annual Philly Tech Week took place from May 5 - 10, 2025, with the goal of celebrating innovation and empowering startups in the region’s thriving tech ecosystem.
2025/2026 PCI Fellows Cohort Announced
The PCI Fellows program is an internship opportunity in technology commercialization that is open to graduate students, postdoctoral fellows and junior research staff at Penn.